U

Mentari Therapeutics, Inc. MTRI

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$18.40$20.00
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
--
My Lists My Alerts
Corporate Info
Phone Number
(916) 445-1254
Address
1625 North Market Blvd.
Suite N112
Sacramento, CA 95834
Country
United States
Year Founded
2025
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
--
Business Description
Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company’s products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.